{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:46Z","timestamp":1787020906945,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Pretoria Doctoral Commonwealth Scholarship","award":["20200846"],"award-info":[{"award-number":["20200846"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vaginal discharge syndrome (VDS) is a common condition. Clinical management targets sexually transmitted infections (STIs) and bacterial vaginosis (BV); there is limited focus on\n                      <jats:italic>Candida<\/jats:italic>\n                      infection as cause of VDS. Lack of\n                      <jats:italic>Candida<\/jats:italic>\n                      treatment coverage and, if present, antifungal resistance may result in VDS treatment failure. This study aimed to determine the prevalence of\n                      <jats:italic>Candida<\/jats:italic>\n                      infection, antifungal resistance, and coinfections in Namibian women with VDS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was performed using 253 vaginal swabs from women with VDS in Namibia. Demographic data was collected, and phenotypic and molecular detection of\n                      <jats:italic>Candida<\/jats:italic>\n                      species was performed followed by fluconazole susceptibility testing of\n                      <jats:italic>Candida<\/jats:italic>\n                      isolates. BV was diagnosed using Nugent score microscopy; molecular detection of\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      ,\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      and\n                      <jats:italic>Trichomonas vaginalis<\/jats:italic>\n                      was performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Candida<\/jats:italic>\n                      species was detected in 110\/253 women (43%). Ninety women (36%) had\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      and 24 (9.5%) had non-albicans\n                      <jats:italic>Candida<\/jats:italic>\n                      species. The non-albicans species detected were 19 (17%)\n                      <jats:italic>Candida glabrata<\/jats:italic>\n                      , 4.0 (3.5%)\n                      <jats:italic>Candida krusei<\/jats:italic>\n                      , and 1.0 (0.9%)\n                      <jats:italic>Candida parapsilosis<\/jats:italic>\n                      .\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      were more frequently isolated in younger (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) and pregnant women (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) compared to non-albicans\n                      <jats:italic>Candida<\/jats:italic>\n                      species. Almost all (98%)\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      isolates were susceptible to fluconazole while all non-albicans\n                      <jats:italic>Candida<\/jats:italic>\n                      species were fluconazole resistant. STIs were diagnosed in 92 women (36%): 30 (12%) with\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      , 11 (4.3%)\n                      <jats:italic>N. gonorrhoeae<\/jats:italic>\n                      , and 70 (28%)\n                      <jats:italic>T. vaginalis<\/jats:italic>\n                      ; 98 (39%) women had BV.\n                      <jats:italic>Candida<\/jats:italic>\n                      infection alone was diagnosed in 30 women (12%), combined with STIs in 42 women (17%) and was concurrent with BV in 38 women (15%).\n                      <jats:italic>Candida<\/jats:italic>\n                      infection was more often detected in swabs from women without\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      detected (6.4% vs. 16%; OR 0.30; 95% CI 0.10\u20130.77,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The high prevalence of\n                      <jats:italic>Candida<\/jats:italic>\n                      infection, especially those due to non-albicans\n                      <jats:italic>Candida<\/jats:italic>\n                      species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes. Access to microbiological testing for\n                      <jats:italic>Candida<\/jats:italic>\n                      species in the context of syndromic management is warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-022-01143-6","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T06:03:08Z","timestamp":1660543388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia"],"prefix":"10.1186","volume":"11","author":[{"given":"Cara M.","family":"Dunaiski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen M.","family":"Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco P. H.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"6","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/OLQ.0000000000000771","volume":"45","author":"ZM Chirenje","year":"2018","unstructured":"Chirenje ZM, Dhibi N, Handsfield HH, Gonese E, Tippett Barr B, Gwanzura L, et al. The etiology of vaginal discharge syndrome in Zimbabwe: results from the Zimbabwe STI etiology study. Sex Transm Dis. 2018;45(6):422\u20138.","journal-title":"Sex Transm Dis"},{"issue":"10","key":"1143_CR2","doi-asserted-by":"publisher","first-page":"e0163365","DOI":"10.1371\/journal.pone.0163365","volume":"11","author":"C Zemouri","year":"2016","unstructured":"Zemouri C, Wi TE, Kiarie J, Seuc A, Mogasale V, Latif A, et al. The performance of the vaginal discharge syndromic management in treating vaginal and cervical infection: a systematic review and meta-analysis. PLoS ONE. 2016;11(10):e0163365.","journal-title":"PLoS ONE"},{"key":"1143_CR3","doi-asserted-by":"publisher","first-page":"1672109","DOI":"10.1155\/2019\/1672109","volume":"2019","author":"S Filardo","year":"2019","unstructured":"Filardo S, Di Pietro M, Tranquilli G, Sessa R. Biofilm in genital ecosystem: a potential risk factor for Chlamydia trachomatis infection. Can J Infect Dis Med Microbiol. 2019;2019:1672109.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"1143_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/jof4040121","volume":"4","author":"O Makanjuola","year":"2018","unstructured":"Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of non-albicans Candida species in vulvovaginitis. J Fungi (Basel). 2018;4(4):121.","journal-title":"J Fungi (Basel)."},{"issue":"1","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"N Kalia","year":"2020","unstructured":"Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19(1):5.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"11","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/OLQ.0000000000000513","volume":"43","author":"G Djomand","year":"2016","unstructured":"Djomand G, Schlefer M, Gutreuter S, Tobias S, Patel R, DeLuca N, et al. Prevalence and correlates of genital infections among newly diagnosed human immunodeficiency virus-infected adults entering human immunodeficiency virus care in Windhoek. Namibia Sex Transm Dis. 2016;43(11):698\u2013705.","journal-title":"Namibia Sex Transm Dis"},{"key":"#cr-split#-1143_CR7.1","unstructured":"Kimberly A. Workowski GAB. Sexually transmitted diseases treatment guideline, 2015. Atlanta, GA 30329-4027. Centers for Disease Control and Prevention, Services USDoHaH"},{"key":"#cr-split#-1143_CR7.2","unstructured":"2015 5 June 2015. Contract No.: 3."},{"issue":"3","key":"1143_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/jof5030075","volume":"5","author":"CM Dunaiski","year":"2019","unstructured":"Dunaiski CM, Denning DW. Estimated burden of fungal infections in Namibia. J Fungi (Basel). 2019;5(3):75.","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"1143_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.7196\/SAMJ.2019.v109i11.13718","volume":"109","author":"IS Schwartz","year":"2019","unstructured":"Schwartz IS, Boyles TH, Kenyon CR, Hoving JC, Brown GD, Denning DW. The estimated burden of fungal disease in South Africa. S Afr Med J. 2019;109(11):885\u201392.","journal-title":"S Afr Med J"},{"key":"1143_CR10","doi-asserted-by":"publisher","first-page":"5930489","DOI":"10.1155\/2016\/5930489","volume":"2016","author":"E Monroy-Perez","year":"2016","unstructured":"Monroy-Perez E, Paniagua-Contreras GL, Rodriguez-Purata P, Vaca-Paniagua F, Vazquez-Villasenor M, Diaz-Velasquez C, et al. High virulence and antifungal resistance in clinical strains of Candida albicans. Can J Infect Dis Med Microbiol. 2016;2016:5930489.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1143_CR11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3389\/fmicb.2016.01995","volume":"7","author":"KR Healey","year":"2016","unstructured":"Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS. Genetic drivers of multidrug resistance in Candida glabrata. Front Microbiol. 2016;7:1995.","journal-title":"Front Microbiol"},{"key":"1143_CR12","doi-asserted-by":"publisher","first-page":"808890","DOI":"10.3389\/fmicb.2022.808890","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wu Y, Lulou K, Yao D, Ying C. Multilocus sequence typing and antifungal susceptibility of vaginal and non-vaginal Candida glabrata isolates from China. Front Microbiol. 2022;13:808890.","journal-title":"Front Microbiol"},{"issue":"4","key":"1143_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-0035-1545909","volume":"75","author":"W Frobenius","year":"2015","unstructured":"Frobenius W, Bogdan C. Diagnostic value of vaginal discharge, wet mount and vaginal pH\u2014an update on the basics of gynecologic infectiology. Geburtshilfe Frauenheilkd. 2015;75(4):355\u201366.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1143_CR14","volume-title":"Namibia standard treatment guidelines 2011","author":"Ministry of Health and Social Services N","year":"2011","unstructured":"Ministry of Health and Social Services N. Namibia standard treatment guidelines 2011. Windhoek: Ministry of Health and Social Services, Namibia; 2011."},{"issue":"5","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/tmi.13046","volume":"23","author":"MS Barry","year":"2018","unstructured":"Barry MS, Ba Diallo A, Diadhiou M, Mall I, Gassama O, Ndiaye Gueye MD, et al. Accuracy of syndromic management in targeting vaginal and cervical infections among symptomatic women of reproductive age attending primary care clinics in Dakar. Senegal Trop Med Int Health. 2018;23(5):541\u20138.","journal-title":"Senegal Trop Med Int Health"},{"issue":"1","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12879-018-3380-6","volume":"18","author":"A Kaida","year":"2018","unstructured":"Kaida A, Dietrich JJ, Laher F, Beksinska M, Jaggernath M, Bardsley M, et al. A high burden of asymptomatic genital tract infections undermines the syndromic management approach among adolescents and young adults in South Africa: implications for HIV prevention efforts. BMC Infect Dis. 2018;18(1):499.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1143_CR17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/tmi.12742","volume":"21","author":"L van der Eem","year":"2016","unstructured":"van der Eem L, Dubbink JH, Struthers HE, McIntyre JA, Ouburg S, Morre SA, et al. Evaluation of syndromic management guidelines for treatment of sexually transmitted infections in South African women. Trop Med Int Health. 2016;21(9):1138\u201346.","journal-title":"Trop Med Int Health"},{"issue":"6","key":"1143_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1473-3099(18)30724-2","volume":"19","author":"MC Verwijs","year":"2019","unstructured":"Verwijs MC, Agaba SK, Sumanyi JC, Umulisa MM, Mwambarangwe L, Musengamana V, et al. Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study. Lancet Infect Dis. 2019;19(6):658\u201369.","journal-title":"Lancet Infect Dis"},{"key":"1143_CR19","doi-asserted-by":"publisher","first-page":"872169","DOI":"10.1155\/2012\/872169","volume":"2012","author":"M Mahmoudi Rad","year":"2012","unstructured":"Mahmoudi Rad M, Zafarghandi A, Amel Zabihi M, Tavallaee M, Mirdamadi Y. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol. 2012;2012:872169.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"1143_CR20","unstructured":"Arendrup MC, Mouton JW, Lagrou K, Hamal P. J Guinea and the subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID EUCAST antifungal MIC method for yeasts 2017. www.eucast.org."},{"issue":"4","key":"1143_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/AOG.0000000000002090","volume":"130","author":"CA Gaydos","year":"2017","unstructured":"Gaydos CA, Beqaj S, Schwebke JR, Lebed J, Smith B, Davis TE, et al. Clinical validation of a test for the diagnosis of vaginitis. Obstet Gynecol. 2017;130(1):181\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1143_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297\u2013301.","journal-title":"J Clin Microbiol"},{"key":"1143_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12879-016-1513-3","volume":"16","author":"JA Dols","year":"2016","unstructured":"Dols JA, Molenaar D, van der Helm JJ, Caspers MP, de Kat A-B, Schuren FH, et al. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity. BMC Infect Dis. 2016;16:180.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1143_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/sti.2006.022376","volume":"83","author":"A Pillay","year":"2007","unstructured":"Pillay A, Radebe F, Fehler G, Htun Y, Ballard RC. Comparison of a TaqMan-based real-time polymerase chain reaction with conventional tests for the detection of Trichomonas vaginalis. Sex Transm Infect. 2007;83(2):126\u20139.","journal-title":"Sex Transm Infect"},{"issue":"9","key":"1143_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/cid\/ciaa260","volume":"72","author":"SL Hillier","year":"2021","unstructured":"Hillier SL, Austin M, Macio I, Meyn LA, Badway D, Beigi R. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis. 2021;72(9):1538\u201343.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1143_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.7196\/SAMJ.2018.v108i10.13027","volume":"108","author":"T Kufa","year":"2018","unstructured":"Kufa T, Gumede L, Maseko DV, Radebe F, Kularatne R. The demographic and clinical profiles of women presenting with vaginal discharge syndrome at primary care facilities in South Africa: associations with age and implications for management. S Afr Med J. 2018;108(10):876\u201380.","journal-title":"S Afr Med J"},{"key":"1143_CR28","doi-asserted-by":"publisher","first-page":"3946862","DOI":"10.1155\/2018\/3946862","volume":"2018","author":"E Morikawa","year":"2018","unstructured":"Morikawa E, Mudau M, Olivier D, de Vos L, Joseph Davey D, Price C, et al. Acceptability and feasibility of integrating point-of-care diagnostic testing of sexually transmitted infections into a South African antenatal care program for HIV-infected pregnant women. Infect Dis Obstet Gynecol. 2018;2018:3946862.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"4","key":"1143_CR29","doi-asserted-by":"publisher","first-page":"e0250044","DOI":"10.1371\/journal.pone.0250044","volume":"16","author":"KM Wall","year":"2021","unstructured":"Wall KM, Nyombayire J, Parker R, Ingabire R, Bizimana J, Mukamuyango J, et al. Etiologies of genital inflammation and ulceration in symptomatic Rwandan men and women responding to radio promotions of free screening and treatment services. PLoS ONE. 2021;16(4):e0250044.","journal-title":"PLoS ONE"},{"issue":"1","key":"1143_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12884-019-2494-1","volume":"19","author":"A Tsega","year":"2019","unstructured":"Tsega A, Mekonnen F. Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019;19(1):527.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"1143_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.mycmed.2018.02.006","volume":"28","author":"O Sy","year":"2018","unstructured":"Sy O, Diongue K, Ahmed CB, Ba O, Moulay FC, Lo B, et al. Vulvovaginal candidiasis in pregnant women in the Mere et Enfant Hospital center in Nouakchott, Mauritania. J Mycol Med. 2018;28(2):345\u20138.","journal-title":"J Mycol Med"},{"issue":"4","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.mycmed.2019.100895","volume":"29","author":"M Bignoumba","year":"2019","unstructured":"Bignoumba M, Onanga R, Bivigou Mboumba B, Gafou A, Mouanga Ndzime Y, Lendamba RW, et al. Vulvovaginal candidiasis among symptomatic women of childbearing age attended at a medical analysis laboratory in Franceville, Gabon. J Mycol Med. 2019;29(4):317\u20139.","journal-title":"J Mycol Med"},{"key":"1143_CR33","first-page":"294","volume":"28","author":"M Kengne","year":"2017","unstructured":"Kengne M, Shu SV, Nwobegahay JM, Achonduh O. Antifungals susceptibility pattern of Candida spp. isolated from female genital tract at the Yaounde Bethesda Hospital in Cameroon. Pan Afr Med J. 2017;28:294.","journal-title":"Pan Afr Med J"},{"issue":"2","key":"1143_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mycmed.2014.01.003","volume":"24","author":"A Ogouyemi-Hounto","year":"2014","unstructured":"Ogouyemi-Hounto A, Adisso S, Djamal J, Sanni R, Amangbegnon R, Biokou-Bankole B, et al. Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. J Mycol Med. 2014;24(2):100\u20135.","journal-title":"J Mycol Med"},{"key":"1143_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/387070","volume":"2014","author":"T Apalata","year":"2014","unstructured":"Apalata T, Carr WH, Sturm WA, Longo-Mbenza B, Moodley P. Determinants of symptomatic vulvovaginal candidiasis among human immunodeficiency virus type 1 infected women in rural KwaZulu-Natal, South Africa. Infect Dis Obstet Gynecol. 2014;2014: 387070.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"4","key":"1143_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2221-1691(12)60025-2","volume":"2","author":"SD Karou","year":"2012","unstructured":"Karou SD, Djigma F, Sagna T, Nadembega C, Zeba M, Kabre A, et al. Antimicrobial resistance of abnormal vaginal discharges microorganisms in Ouagadougou, Burkina Faso. Asian Pac J Trop Biomed. 2012;2(4):294\u20137.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"1143_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S2222-1808(12)60011-5","volume":"2","author":"NN Emmanuel","year":"2012","unstructured":"Emmanuel NN, Romeo O, Mebi AG, Mark OO, Scordino F, Bessy EI, et al. Genotyping and fluconazole susceptibility of Candida albicans strains from patients with vulvovaginal candidiasis in Jos, Nigeria. Asian Pac J Trop Dis. 2012;2(1):48\u201350.","journal-title":"Asian Pac J Trop Dis"},{"issue":"1","key":"1143_CR38","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s13104-019-4793-z","volume":"12","author":"MF Mushi","year":"2019","unstructured":"Mushi MF, Mmole A, Mshana SE. Candida vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania. BMC Res Notes. 2019;12(1):775.","journal-title":"BMC Res Notes"},{"issue":"1","key":"1143_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12905-018-0607-z","volume":"18","author":"A Bitew","year":"2018","unstructured":"Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18(1):94.","journal-title":"BMC Womens Health"},{"issue":"8","key":"1143_CR40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4103\/njcp.njcp_25_16","volume":"21","author":"UU Aniebue","year":"2018","unstructured":"Aniebue UU, Nwankwo TO, Nwafor MI. Vulvovaginal candidiasis in reproductive age women in Enugu Nigeria, clinical versus laboratory-assisted diagnosis. Niger J Clin Pract. 2018;21(8):1017\u201322.","journal-title":"Niger J Clin Pract"},{"issue":"1","key":"1143_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4314\/ahs.v20i1.9","volume":"20","author":"C Mbakwem-Aniebo","year":"2020","unstructured":"Mbakwem-Aniebo C, Osadebe AU, Athanasonny E, Okonko IO. Prevalence of Candida spp. and age-related disparities amongst women presenting with vaginitis at the Obstetrics and Gynaecology (O&G) Clinic in a Tertiary hospital in Port Harcourt, Nigeria. Afr Health Sci. 2020;20(1):51\u20138.","journal-title":"Afr Health Sci"},{"issue":"3","key":"1143_CR42","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4103\/2141-9248.133470","volume":"4","author":"T Apalata","year":"2014","unstructured":"Apalata T, Longo-Mbenza B, Sturm A, Carr W, Moodley P. Factors associated with symptomatic vulvovaginal candidiasis: a study among women attending a primary healthcare clinic in Kwazulu-Natal, South Africa. Ann Med Health Sci Res. 2014;4(3):410\u20136.","journal-title":"Ann Med Health Sci Res"},{"key":"1143_CR43","first-page":"23","volume":"43","author":"GE Imadea","year":"2014","unstructured":"Imadea GE, Musa J, Sagaya AS, Kapigac SH, Sankaled J-L, Idokob J, Kankid P. Association of bacterial vaginosis and other sexually transmitted infections with HIV among pregnant women in Nigeria. Afr J Med Med Sci. 2014;43:23\u20138.","journal-title":"Afr J Med Med Sci"},{"key":"1143_CR44","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3389\/fmicb.2018.03270","volume":"9","author":"MD Kruppa","year":"2018","unstructured":"Kruppa MD, Jacobs J, King-Hook K, Galloway K, Berry A, Kintner J, et al. Binding of elementary bodies by the opportunistic fungal pathogen Candida albicans or soluble beta-glucan, laminarin, inhibits Chlamydia trachomatis infectivity. Front Microbiol. 2018;9:3270.","journal-title":"Front Microbiol"},{"issue":"8","key":"1143_CR45","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-0041-1735299","volume":"43","author":"A Melo","year":"2021","unstructured":"Melo A, Ossa X, Fetis G, Lazo L, Bustos L, Fonseca-Salamanca F. Concordance between clinical and laboratory diagnosis of abnormal vaginal discharge in Chilean women. Rev Bras Ginecol Obstet. 2021;43(8):600\u20137.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"1","key":"1143_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/sti.2003.004192","volume":"80","author":"E Rylander","year":"2004","unstructured":"Rylander E, Berglund AL, Krassny C, Petrini B. Vulvovaginal Candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80(1):54\u20137.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"1143_CR47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mycmed.2017.08.006","volume":"28","author":"I Sangare","year":"2018","unstructured":"Sangare I, Sirima C, Bamba S, Zida A, Cisse M, Bazie WW, et al. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. J Mycol Med. 2018;28(1):186\u201392.","journal-title":"J Mycol Med"},{"issue":"4","key":"1143_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.9734\/BMRJ\/2015\/13804","volume":"5","author":"KJ Mukasa","year":"2015","unstructured":"Mukasa KJ, Herbert I, Daniel A, Sserunkuma KL, Joel B, Frederick B. Antifungal susceptibility patterns of vulvovaginal Candida species among women attending antenatal clinic at Mbarara Regional Referral Hospital, South Western Uganda. Br Microbiol Res J. 2015;5(4):322\u201331.","journal-title":"Br Microbiol Res J"},{"issue":"suppl_3","key":"1143_CR49","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445\u201351.","journal-title":"J Infect Dis"},{"issue":"10","key":"1143_CR50","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2217\/fmb-2018-0059","volume":"13","author":"J Beardsley","year":"2018","unstructured":"Beardsley J, Halliday CL, Chen SC, Sorrell TC. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Fut Microbiol. 2018;13(10):1175\u201391.","journal-title":"Fut Microbiol"},{"key":"1143_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237\u201345.","journal-title":"Infect Drug Resist"},{"issue":"Suppl 2","key":"1143_CR52","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1093\/infdis\/jiz573","volume":"221","author":"M Xiao","year":"2020","unstructured":"Xiao M, Chen SC, Kong F, Xu XL, Yan L, Kong HS, et al. Distribution and antifungal susceptibility of Candida species causing candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020;221(Suppl 2):S139\u201347.","journal-title":"J Infect Dis"},{"key":"1143_CR53","doi-asserted-by":"publisher","first-page":"655069","DOI":"10.3389\/fmicb.2021.655069","volume":"12","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, Kargar ML, Mohammadi SR, Roudbary M, Ghods N, Haghighi L, et al. A high rate of recurrent vulvovaginal candidiasis and therapeutic failure of azole derivatives among Iranian women. Front Microbiol. 2021;12:655069.","journal-title":"Front Microbiol"},{"key":"1143_CR54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/IDR.S153116","volume":"11","author":"M Khan","year":"2018","unstructured":"Khan M, Ahmed J, Gul A, Ikram A, Lalani FK. Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infect Drug Resist. 2018;11:447\u201356.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"1143_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bjm.2016.09.006","volume":"48","author":"TM Brandolt","year":"2017","unstructured":"Brandolt TM, Klafke GB, Goncalves CV, Bitencourt LR, Martinez AM, Mendes JF, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol. 2017;48(1):145\u201350.","journal-title":"Braz J Microbiol"},{"issue":"1","key":"1143_CR56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12884-020-02963-3","volume":"20","author":"SD Waikhom","year":"2020","unstructured":"Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020;20(1):266.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"1143_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jiph.2016.06.003","volume":"10","author":"C Tellapragada","year":"2017","unstructured":"Tellapragada C, Eshwara VK, Bhat P, Kamath A, Aletty S, Mukhopadhyay C. Screening of vulvovaginal infections during pregnancy in resource constrained settings: implications on preterm delivery. J Infect Public Health. 2017;10(4):431\u20137.","journal-title":"J Infect Public Health"},{"issue":"1 Suppl","key":"1143_CR58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21010\/ajid.v12i1S.13","volume":"12","author":"DS Arfiputri","year":"2018","unstructured":"Arfiputri DS, Hidayati AN, Handayani S, Ervianti E. Risk factors of vulvovaginal candidiasis in dermato-venereology outpatients clinic of Soetomo Heneral Hospital, Surabaya, Indonesia. Afr J Infect Dis. 2018;12(1 Suppl):90\u20134.","journal-title":"Afr J Infect Dis"},{"issue":"2","key":"1143_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","volume":"36","author":"S Silva","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288\u2013305.","journal-title":"FEMS Microbiol Rev"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01143-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T14:57:30Z","timestamp":1700924250000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01143-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01143-6","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Human Research Ethics Committee of the University of the Pretoria (Ref: 518\/2020), the Namibia University of Science and Technology Faculty of Health and Applied Sciences Research Ethics Board (Ref: FHAS 11\/2020) and regulatory approval from the Namibian Ministry of Health and Social Services (Ref: 17\/3\/3\/CMD). As approved by the Ethics committees, anonymised swabs were used and no individual informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}